Table of Contents
A 2024 systematic review pooled 20 studies and 2,959 participants to assess how psilocybin affects thinking. Results were mixed: global cognition and processing speed were largely unchanged in healthy adults, while patients with treatment-resistant depression showed some improvements in attention, working memory, and emotional processing.
- Global cognition held steady in healthy volunteers across most studies, suggesting that macrodose psilocybin does not broadly impair or enhance general thinking in non-clinical populations.
- Emotional processing improved, particularly in patients with treatment-resistant depression, and emotional empathy appeared to increase without meaningful changes to cognitive empathy or social cognition.
- Creativity and flexibility showed a two-phase pattern: cognitive flexibility and creative cognition initially declined during or shortly after dosing, but some evidence suggested the possibility of longer-term improvement.
- Memory effects were selective: semantic associations and associative learning showed promise, while episodic and verbal memory effects were less notable compared to other cognitive enhancers studied in the literature.
- Model
- Human
- Sample
- 2,959 participants across 20 articles; 85% healthy volunteers
- Dose
- Predominantly macrodoses, ranging from 45 micrograms per kilogram to 30 mg per 70 kg bodyweight
- Design
- Systematic review of electronic databases, searched from inception through January 2024
- Key outcome
- Mixed results across cognitive domains; clearest signals in emotional processing and select memory types, especially in treatment-resistant depression patients
- Main limitation
- Heterogeneous study designs, mostly healthy-volunteer samples, and limited clinical-population data make firm conclusions premature
What the Research Examined
This is a systematic review published in 2024 and indexed through the National Institutes of Health. The authors searched multiple electronic databases from inception through January 2024, ultimately identifying 20 peer-reviewed articles that examined psilocybin’s effects on cognitive function. The combined participant pool across those studies totaled 2,959 individuals. Roughly 85 percent of the underlying studies were conducted in healthy volunteers rather than clinical populations, and 85 percent of those studies used macrodoses, spanning a range from 45 micrograms per kilogram up to 30 milligrams per 70 kilograms of bodyweight.
The review covered a broad set of cognitive domains: global cognitive function, processing speed, sustained attention, working memory, executive function, emotional processing, empathy, social cognition, cognitive flexibility, creative cognition, and several categories of learning and memory. Findings varied considerably by domain and by population. For anyone wanting to understand the wider landscape of psilocybin’s proposed mechanisms and early clinical evidence, this review provides a useful cross-section of where the science currently stands.
The authors note that psilocybin is converted in the body to its active metabolite psilocin, which interacts with serotonin receptors including 5-HT2A, an interaction thought to underlie its perceptual and emotional effects. The review situates these findings within the framework of neuroplasticity, the brain’s capacity for structural and functional adaptation, as one potential pathway through which cognitive change may occur. The authors conclude that further, more methodologically consistent research is needed before any definitive picture of psilocybin’s cognitive profile can emerge.
What the Findings Show
- Studies and participants.20 articles were included, covering a total of 2,959 participants. Approximately 85 percent of studies enrolled healthy volunteers.
- Global cognition and processing speed.These domains remained mostly unchanged in healthy individuals across the reviewed studies.
- Attention, working memory, and executive function.A limited number of studies reported improvements in these areas, with the signal appearing most clearly in patients with treatment-resistant depression rather than in healthy volunteers.
- Emotional empathy vs. cognitive empathy.Psilocybin was observed to enhance emotional empathy without significantly altering cognitive empathy or social cognition. Emotional processing was positively modified, particularly in treatment-resistant depression patients.
Two domains showed a pattern worth noting separately. Cognitive flexibility and creative cognition both appeared to initially decline at or near the time of dosing, but the review notes these could potentially improve over longer follow-up windows. On the memory side, semantic associations and associative learning showed more promise than episodic or verbal memory, which were less pronounced in their effects compared to other cognitive-enhancing compounds examined in the broader literature. The authors describe the overall picture as reflecting the genuine complexity of psilocybin’s cognitive influence rather than a simple enhancing or impairing story.
Does psilocybin improve cognitive function?
Based on a 2024 systematic review of 20 studies, the answer is: it depends on the domain and the population. Global cognition and processing speed were largely stable. Some improvements in attention, working memory, and emotional processing appeared, most clearly in patients with treatment-resistant depression rather than in healthy adults.
What This Is, and What It Is Not
This is This is a systematic review summarizing 20 existing studies, the majority of which were conducted in healthy volunteers using macrodoses of psilocybin, with heterogeneous designs and outcome measures.
This is not This review is not a clinical trial and does not establish that psilocybin treats or improves any cognitive condition. It does not provide guidance on dosing, and its findings in clinical populations are based on a small subset of the included studies. Nothing here constitutes medical advice.
Our Take
Within this community, we hold psilocybin as a sacrament that can open channels of perception and feeling that ordinary waking life tends to close. What this review adds, from a purely scientific vantage point, is a map of the terrain: not a straight road toward enhancement, but a varied landscape where emotional openness seems to expand, some forms of memory and learning may shift, and raw cognitive throughput stays largely intact. That picture is honest, and honesty is something we value as much as wonder. The complexity the authors identify is not a weakness in the science. It is an invitation to look more carefully at what we mean when we ask whether a substance improves the mind.
If you are drawn to understanding what psilocybin actually does, as opposed to what we might wish it did, then you are already practicing something important: discernment. Whether you are early in the Grounding station, learning to distinguish signal from noise, or further along in Integration, trying to make sense of what an experience has left behind, that same careful attention serves you well. We share this research not to persuade but to inform. Sit with what resonates, hold what is uncertain lightly, and come back whenever you want to go deeper.
Frequently Asked Questions
What cognitive effects does psilocybin have?
A 2024 systematic review found mixed results. Global thinking and processing speed were largely unchanged in healthy people. Some improvements in attention, working memory, and emotional processing appeared, mainly in patients with treatment-resistant depression. Creative thinking initially declined but may improve over time.
Does psilocybin help with memory?
The review found some evidence suggesting psilocybin may benefit semantic associations and associative learning. Effects on episodic and verbal memory were less notable. These findings come from a heterogeneous set of early studies, not from established clinical practice.
Does psilocybin increase empathy?
The review found that psilocybin appeared to enhance emotional empathy without significantly changing cognitive empathy or social cognition. This pattern appeared particularly in patients with treatment-resistant depression. Results across the full body of studies were mixed.
Is psilocybin safe for cognitive function?
The review did not find evidence of broad cognitive harm in healthy volunteers, but it also identified areas like creative thinking and cognitive flexibility that temporarily declined. The authors call for more rigorous research before conclusions about safety or benefit can be drawn.
How many studies have looked at psilocybin and cognition?
This 2024 systematic review identified 20 articles meeting its inclusion criteria, covering nearly 3,000 participants in total. The authors note that most studies used healthy volunteers and macrodoses, leaving clinical populations relatively understudied.
Get the Mycelium Report
We read the new psilocybin and mushroom research so you do not have to. One honest, jargon-free dispatch, delivered daily. Free to join.
May love guide the hearts of all beings.
